Poster Presentations
From CREST “The Immune System”
| No. | Principal Investigator | Presenter | Affiliation | Poster Title | |
|---|---|---|---|---|---|
| CIS -01 |
Yoichiro IWAKURA | Aoi AKITSU | Tokyo Univ. of Science | Elucidation of the pathogenic mechanisms of allergic and autoimmune diseases and development of new therapeutics targeted on IL-17 family molecules and C-type lectin receptors. |  |
| CIS -02 |
Yoichiro IWAKURA | Masanori A. MURAYAMA | Tokyo Univ. of Sci. | The complement regulator CTRP6 can suppress the development of collagen-induced arthritis in mice | |
| CIS -03 |
Toshiaki OHTEKI | Nobuyuki ONAI | Tokyo Med. Dent. Univ. | Identification of new DC progenitors with prominent pDC differentiation potential | |
| CIS -04 |
Toshiyuki TAKAI | Toshifumi KIMURA | Tohoku Univ. | Novel immunotherapies exploiting inhibitory mechanisms of immunoreceptors | |
| CIS -05 |
Shigekazu NAGATA | Shigekazu Nagata （Presented in Poster Session II) | Kyoto Univ. | Engulfment and degradation of apoptotic cells, and its failure | |
| CIS -06 |
Toshio HIRANO | Masaaki MURAKAMI | Osaka Univ. | Mechanics of organ specific inflammatory/autoimmune diseases and the development of its control approach | |
| CIS -07 |
Yoshinori FUKUI | Yoshihiko Tanaka | Kyushu Univ. | A novel strategy for treatment of immune-related disorders by using cytoskeleton regulating signals as targets | |
| CIS -08 |
Yoshinori FUKUI | Yosuke HARADA | Kyushu Univ. | DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune response | |
| CIS -09 |
Akihiko YOSHIMURA | Shigenori NAGAI | Keio Univ. | PI3K-Akt-mTORC1 pathway regulates Th17 differentiation by controlling Gfi1 expression and nuclear translocation of RORγt | |
| CIS -10 |
Hisashi ARASE | Hisashi ARASE | Osaka Univ. | Regulation of immune response and infection by targeting paired receptors. | |
| CIS -11 |
Taku OKAZAKI | Il-mi OKAZAKI | Tokushima Univ. | Identification of new therapeutic targets by genetic dissection and reconstitution of autoimmune diseases in mice. | |
| CIS -12 |
Hajime KARASUYAMA | Mayumi EGAWA | Tokyo Med. Dent. Univ. | Novel mechanisms of allergy and its regulation | |
| CIS -13 |
Tatsuo KINASHI | Yoshihiro UEDA | Kansai Med. Univ. | Disregulated of immune-cell trafficking signaling and development of autoimmunity | |
| CIS -14 |
Tomohiro KUROSAKI | Wataru Ise | Osaka Univ. | Development of a novel way to treat autoimmune disease by regulating humoral immune systems | |
| CIS -15 |
Tadatsugu TANIGUCHI | Ryuji KOSHIBA | The Univ. of Tokyo | Analysis of the IRF-3- or HMGB1-mediated regulation of innate immune responses against nucleic acid. | |
| CIS -16 |
Akira SHIBUYA | Satoko-Tahara-HANAOKA | Univ. of Tsukuba | Control of allergic diseases by regulation of mast cell activation" | |
| CIS -17 |
Akira SHIBUYA | Yumi Yamashita | Univ. of Tsukuba | CD155 mediates a costimulatory signal for Th1 development and is involved in the development of allergic diseases | |
| CIS -18 |
Kiyoshi TAKEDA | Kiyoshi TAKEDA | Osaka Univ. | Dietary folic acid is responsible for maintenance of colonic regulatory T cells | |
